meet our people.

Jing Zhang

MD PhD FRCSC
  • P613-798-5555 ext. 13165

Dr. Jing Zhang is a plastic surgeon with a special interest in breast surgery, hand surgery and reconstructive microsurgery.

Dr. Zhang received her medical degree from Chongqing Medical School in China (1998). She obtained a Ph.D in Oncology at the University of Alberta (2005) and in 2013 she pursued her residency training in plastic and reconstructive surgery at the University of Toronto. Her fellowship training included a hand and upper extremity surgery at the University of Toronto (2013) and microsurgical breast reconstruction at the University of Manitoba (2014).

Dr. Zhang began her practice at the University of Ottawa in 2013 and was appointed Staff Surgeon at The Ottawa Hospital in 2014. She believes in excellence in patient care, medical research and student education.

Additional Info

Clinical Interests
  • Microsurgical breast reconstruction
  • Reconstruction post tumor ablation and trauma
  • Hand surgery
Certifications
  • Fellow of Royal College of Surgeons of Canada (2013)
Publications
  1. Zhong T, Novak CB, Bagher S, Maass SW, Zhang J, Arad U, O’Neill AC, Metcalfe KA, Hofer SO. (2014) Using propensity score analysis to compare major complications between DIEP and free muscle-sparing TRAM flap breast reconstructions. Plast Reconstr Surg 133(4):774-82.
  2. Lepist EI, Damaraju VL, Zhang J, Gati WP, Yao SY, Smith KM, Karpinski E, Young JD, Leung KH, Cass CE. (2013) Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. Drug Metab Dispos. 41(4):916-22.
  3. Zhong T, McCarthy C, Min S, Zhang J, Beber B, Pusic A, Hofer SOP. (2012) Patient satisfaction and health-related quality of life following autologous tissue breast reconstruction: A prospective analysis of early postoperative outcomes. Cancer 118(6):1701-9.
  4. Zhang J, Visser F, King KM, Baldwin SA, Young JD, Cass CE. (2007) The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs. Cancer Metastasis Rev. 26(1):85-110, Review.
  5. Slugoski MD, Smith KM, Mulinta R, Ng AM, Yao SY, Morrison EL, Lee QO, Zhang J, Karpinski E, Cass CE, Baldwin SA, Young JD. (2008) A conformationally mobile cysteine residue (Cys-561) modulates Na+ and H+ activation of human CNT3. J Biol Chem. 283(36): 24922-34.
  6. Paproski RJ, Visser F, Zhang J, Tackaberry T, Damaraju V, Baldwin SA, Young JD, Cass CE. (2008) Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity. Biochem J. 14(2):291-300.
  7. Zhang J, Sun X, Smith KM, Carpenter P, Barron G, Robins M, Baldwin SA,Young JD, Cass CE. (2006) Studies of nucleoside transporters using autofluorescent nucleoside analogs.  Biochemistry 45(4):1087-1098.
  8. Zhang J, Smith KM, Tackaberry T, Sun X, Carpenter P, Slugoski MD, Robins MJ, Nielsen LP, Nowak I, Baldwin SA, Young JD, Cass CE.  (2006) Characterization of the transport mechanism and permeant binding profile of the uridine permease Fui1p of saccharomyces cerevisiae. J Biol Chem. 281(38): 28210-21.
  9. Zhang J, Tackaberry T, Barron G, Baldwin SA, Young JD, Cass CE. (2006) Cysteine accessibility analysis of transmembrane domain 11, 12 and 13 of human concentrative nucleoside transporter 3. Biochemical Journal 394(Pt 2):389-98.
  10. Clarke ML, Damaraju VL, Zhang J, Mowles D, Tackaberry T, Lang T, Smith KM, Young JD, Tomkinson B, Cass CE. (2006) Uptake of 4′-thio-ß-D-arabinofuranosylcytosine and ß-D-arabinosylcytosine by human nucleoside transporters. Mol Pharmacol 70 (1): 303-10.
  11. Zhang J, Smith KM, Tackaberry T, Visser F, Robins MJ, Nielsen LP, Nowak I, Baldwin SA, Young JD, Cass CE. (2005) Uridine binding and transportability determinants of human concentrative nucleoside transporters. Mol Pharmacol 68(3): 830-839.
  12. Damaraju* S, Zhang* J, Visser F, Tackaberry T, Dufour J, Baldwin SA, Young JD, Cass CE. (2005) Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene. Pharmacogenetics 15:173-182. (* These authors contributed equally to this work.)
  13. Visser F, Zhang J, Roborn RT, Baldwin SA, Young JD, Cass CE. (2005) Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites. Mol Pharmacol 67:1291-1298.
  14. Vickers* MF, Zhang* J, Visser F, Tackaberry T, Robins MJ, Nielsen LP, Nowak I, Baldwin SA, Young JD, Cass CE. (2004) Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiae. Nucleosides, Nucleotides & Nucleic Acids 23: 361-73. (*These authors contributed equally to this work.)
  15. Zhang J, Visser F, Vickers MF, Lang T, Robins MJ, Nielsen LP, Nowak I, Baldwin SA, Young JD, Cass CE. (2003) Uridine binding motifs of human concentrative nucleoside transporters 1 and 3 produced in Saccharomyces cerevisiae. Mol Pharmacol 64: 1512-1520.
  16. Wang R, Xu C, Zhao W, Zhang J, Cao K, Yang B, Wu L. (2003) Calcium and polyamine regulated calcium-sensing receptors in cardiac tissues. Eur J Biochem 270: 2680-2688.
  17. Vickers, MF, Kumar R, Visser F, Zhang J, Charania J, Raborn RT, Baldwin SA, Young JD, Cass CE. (2002) Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae. Biochem Cell Biol 80: 639-644.
  18. Zhao W, Zhang J, Lu Y, Wang R. (2001) The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 20: 6008-6016.
  19. Lu Y, Zhang J, Tang G, Wang R. (2001) Modulation of voltage-dependent K+channel current in vascular smooth muscle cells from rat mesenteric arteries. J Membr Biol 180: 163-175.
  20. Zhang J, Yao Z. (2000) Effect of 1,25(OH)2D3 on the growth and apoptosis of breast cancer cell line MCF-7. Chin Med J (Engl) 113: 124-128.
  21. Zhang J, Yao Z. (1999) Current research on molecular markers of thyroid carcinoma. Bulletin of Chongqing Medical University (Chinese) 60: 146-148.
  22. Zhang J, Yao Z. (1997) Views on pancreas transplantation. Journal of Basic and Clinical Research on General Surgery (Chinese), 4.